NAS
TCON

Nicolet Advisory Services’s TRACON Pharmaceuticals, Inc. Common Stock TCON Stock Holding History

Nicolet Advisory Services’s Portfolio TCON Stock Details TCON Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-179
Closed -$16K – 176
2019
Q3 		$16K Hold
179
– – ﹤0.01% 163
2019
Q2 		$24K Hold
179
– – ﹤0.01% 158
2019
Q1 		$49K Buy
+179
New +$38.8K 0.01% 148

Other funds holding TCON

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
LA
Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
JJIJ
Johnson & Johnson Innovation - JJDC New Brunswick, New Jersey $978M AUM 102.17% 1-Year Est. Return
PCM
Puissance Capital Management New York $17.3M AUM 149.36% 1-Year Est. Return
TI
Telemetry Investments New York $63.3M AUM 0.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
ARTA
A.R.T. Advisors New York $1.79M AUM 57.47% 1-Year Est. Return

Nicolet Advisory Services's TCON Position: Q4 2019 in Review

Nicolet Advisory Services sold out of TRACON Pharmaceuticals, Inc. Common Stock (TCON) in Q4 2019, closing a stake of 179 shares — an estimated $16K sold.

Nicolet Advisory Services first reported a position in TCON in Q1 2019 and held it in 3 quarters. The position peaked at $49K in Q1 2019. 15 funds tracked by Wall St. Rank hold TCON as of Q4 2019.

  • Nicolet Advisory Services reported no remaining TRACON Pharmaceuticals, Inc. Common Stock position as of Q4 2019 after selling out during the quarter.
  • Nicolet Advisory Services sold 179 TRACON Pharmaceuticals, Inc. Common Stock shares in Q4 2019, an estimated $16K.
  • Nicolet Advisory Services first reported a position in TRACON Pharmaceuticals, Inc. Common Stock in Q1 2019 and held it in 3 quarters.
  • Nicolet Advisory Services's TRACON Pharmaceuticals, Inc. Common Stock position peaked at $49K in Q1 2019.
  • 15 funds tracked by Wall St. Rank held TRACON Pharmaceuticals, Inc. Common Stock as of Q4 2019.

Based on Nicolet Advisory Services's 13F filing for Q4 2019, filed 23 Jan 2020.